A Promising Obesity Drug with Robert Kushner, MD

The medication semaglutide, commonly prescribed for treatment of Type 2 diabetes, was made use of in a stage 3 medical trial as a treatment for obesity with really appealing outcomes. Northwestern's Robert Kushner, MD, led this study, just recently published in the New England Journal of Medicine as well as shares the outcomes.

Leave a Reply

Your email address will not be published. Required fields are marked *